Cationic polypeptides are required for antibacterial activity of human airway fluid

Journal of Immunology

Volumn 169, Issue 12, 2002, Pages 6985-6991

  Cole, Alexander M ^a,b   Liao, Hsiang I ^a,b   Stuchlik, Olga ^c   Tilan, Jason ^a,b   Pohl, Jan ^c   Ganz, Tomas ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOFERRIN; LYSOZYME; POLYPEPTIDE; PROTEINASE INHIBITOR; RESIN; ANTIMICROBIAL CATIONIC PEPTIDE; CATION EXCHANGE RESIN; LEUKOCYTE ELASTASE INHIBITOR; PROTEIN;

AIRWAY; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; CATION EXCHANGE; COLONY FORMING UNIT; ENZYME ACTIVITY; ESCHERICHIA COLI; HOST RESISTANCE; HUMAN; HUMAN CELL; LISTERIA MONOCYTOGENES; NOSE SECRETION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TWO DIMENSIONAL GEL ELECTROPHORESIS; CHEMISTRY; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; HEAT; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; NOSE MUCOSA; NOSE MUCUS; PHYSIOLOGY; SECRETION;

ANTIMICROBIAL CATIONIC PEPTIDES; CATION EXCHANGE RESINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESCHERICHIA COLI; HEAT; HUMANS; LACTOFERRIN; LISTERIA MONOCYTOGENES; MURAMIDASE; NASAL LAVAGE FLUID; NASAL MUCOSA; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; PSEUDOMONAS AERUGINOSA;

EID: 0037114149     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.12.6985     Document Type: Article

References (48)

1. Lehrer, R. I., C. L. Bevins, and T. Ganz. 1999. Defensins and other antimicrobial peptides. In Mucosal Immunology. P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, and J. R. McGhee, eds. Academic, San Diego, p. 89.
2. Travis, S. M., P. K. Singh, and M. J. Welsh. 2001. Antimicrobial peptides and proteins in the innate defense of the airway surface. Curr. Opin. Immunol. 13:89.
3. Ellison, R. T. III, and T. J. Giehl. 1991. Killing of Gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest. 88:1080.
4. Raphael, G. D., E. V. Jeney, J. N. Baraniuk, I. Kim, S. D. Meredith, and M. A. Kaliner. 1989. Pathophysiology of rhinitis: lactoferrin and lysozyme in nasal secretions, J. Clin. Invest. 84:1528.
5. Westin, U., U. Fryksmark, A. Polling, and K. Ohlsson. 1994. Localisation of secretory leucocyte proteinase inhibitor mRNA in nasal mucosa. Acta Otolaryngol. 114:199.
6. Fryksmark, U., K. Ohtsson, A. Polling, and H. Tegner. 1982. Distribution of antileukoprotease in upper respiratory mucosa. Ann. Otol. Rhinol. Laryngol. 91:268.
7. McNeely, T. B., M. Dealy, D. J. Dripps, J. M. Orenstein, S. P. Eisenberg, and S. M. Wahl. 1995. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Invest. 96:456.
8. Hiemstra, P. S., R. J. Maassen, J. Stolk, R. Heinzel-Wieland, G. J. Steffens, and J. H. Dijkman. 1996. Antibacterial activity of antileukoprotease. Infect. Immun. 64:4520.
9. Tomee, J. F., P. S. Hiemstra, R. Heinzel-Wieland, and H. F. Kauffman. 1997. Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J. Infect. Dis. 176:740.
10. Akinbi, H. T., R. Epaud, H. Bhatt, and T. E. Weaver. 2000. Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice. J. Immunol. 165:5760.
11. Revenis, M. E., and M. A. Kaliner. 1992. Lactoferrin and lysozyme deficiency in airway secretions: association with the development of bronchopulmonary dysplasia. J. Pediatr. 127:262.
12. Schonwetter, B. S., E. D. Stolzenberg, and M. A. Zasloff. 1995. Epithelial antibiotics induced at sites of inflammation. Science 267:1645.
13. Ganz, T. 1999. Defensins and host defense. Science 286:420.
14. Ludtke, S, J., K, He. W. T. Heller, T. A. Harroun, L. Yang, and H. W. Huang. 1996. Membrane pores induced by magainin. Biochemistry 35:13723.
15. Mangoni, M. E., A. Aumelas, P, Charnet, C. Roumestand, L. Chiche, E. Despaux, G. Grassy, B. Calas, and A. Chavanieu. 1996. Change in membrane permeability induced by protegrin I: implication of disulphide bridges for pore formation. FEBS Lett. 383:93.
16. McCray, P. B., and L. Bentley. 1997. Human airway epithelia express a β-defensin. Am. J. Respir. Cell Mol. Biol. 16:343.
17. Singh, P. K., H. P. Jia, K. Wiles, J. Hesselberth, L. Liu, B. D. Conway, E. P. Greenberg, E. V. Valore, M. J. Welsh, T. Ganz, et al. 1998. Production of β-defensins by human airway epithelia. Proc. Natl. Acad. Sci. USA 95:14961.
18. Ganz, T., M. E. Selsted, D. Szklarek, S. S. Harwig, K. Daher, D. F. Bainton, and R. I. Lehrer. 1985. Defensins: natural peptide antibiotics of human neutrophils. J. Clin. Invest. 76:1427.
19. Schnapp, D., and A. Harris. 1998. Antibacterial peptides in bronchoalveolar lavage fluid. Am. J. Respir. Cell Mol. Biol. 19:352.
20. Brogden, K. A., M. Ackermann, and K. M. Huttner. 1998. Detection of anionic antimicrobial peptides in ovine bronchoalveolar lavage fluid and respiratory epithelium. Infect. Immun. 66:5948.
21. Brogden, K. A., M. R. Ackermann, P. B. McCray, Jr., and K. M. Huttner. 1999. Differences in the concentrations of small, anionic, antimicrobial peptides in bronchoalveolar lavage fluid and in respiratory epithelia of patients with and without cystic fibrosis. Infect. Immun. 67:4256.
22. Harder, J., J. Bartels, E. Christophers, and J.-M. Schroeder. 1997. A peptide antibiotic from human skin. Nature 387:861.
23. Zhao, C. Q., I. Wang, and R. I. Lehrer. 1996. Widespread expression of β-defensin HBD-I in human secretory glands and epithelial cells. FEBS Lett. 396:319.
24. Cole, A. M., P. Dewan, and T. Ganz. 1999. Innate antimicrobial activity of nasal secretions. Infect. Immun. 67:3267.
25. Valore, E. V., C. H. Park, A. J. Quayle, K. R. Wiles, P. B. McCray, and T. Ganz. 1998. Human β-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101:1633.
26. Schagger, H., and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368.
27. Liu, L., L. Wang, H. P. Jia, C. Zhao, H. H. Q. Heng, B. C. Schutte, P. B. McCray, and T. Ganz. 1998. Structure and mapping of the human β-defensin HBD-2 gene and its expression at sites of inflammation. Gene 222:237.
28. Osserman, E. F., and D. P. Lawlor. 1966. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J. Exp. Med. 124:921.
29. Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229.
30. Lee, I. H., Y. Cho, and R. I. Lehrer. 1997. Effects of pH and salinity on the antimicrobial properties of clavanins. Infect. Immun. 65:2898.
31. Lehrer, R. I., M. Rosenman, S. S. Harwig, R. Jackson, and P. Eisenhauer. 1991. Ultrasensitive assays for endogenous antimicrobial polypeptides. J. Immunol. Methods. 137:167.
32. Cole, A. M., M. Wu, Y. H. Kim, and T. Ganz. 2000. Microanalysis of antimicrobial properties of human fluids. J. Microbiol. Methods 41:135.
33. Hewick, R. M., M. W. Hunkapiller, L. E. Hood, and W. J. Dreyer. 1981. A gas-liquid solid phase peptide and protein sequenator. J. Biol. Chem. 256:7990.
34. Rosenfeld, J., J. Capdevielle, J. C. Guillemot, and P. Ferrara. 1992. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal. Biochem. 203:173.
35. Hubalek, F., D. E. Edmondson, and J. Pohl. 2002. Synthesis and characterization of a collagen model δ-O-phosphohydroxylysine-containing peptide. Anal. Biochem. 306:124.
36. Singh, P. K., M. R. Parsek, E. P. Greenberg, and M. J. Welsh. 2002. A component of innate immunity prevents bacterial biofilm development. Nature 417:552.
37. Travis, S. M., B. A. Conway, J. Zabner, J. J. Smith, N. N. Anderson, P. K. Singh, E. P. Greenberg, and M. J. Welsh. 1999. Activity of abundant antimicrobials of the human airway. Am. J. Respir. Cell Mol. Biol. 20:872.
38. Fryksmark, U., M. Jannert, K. Ohlsson, H. Tegner, and J. A. Wihl. 1989. Secretory leukocyte protease inhibitor in normal, allergic, and virus-induced nasal secretions. Rhinology 27:97.
39. Harder, J., J. Bartels, E. Christophers, and J. M. Schroder. 2001. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707.
40. Daher, K. A., M. E. Selsted, and R. I. Lehrer. 1986. Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60:1068.
41. Jones, D. E., and C. L. Bevins. 1992. Paneth cells of the human small intestine express an antimicrobial peptide gene. J. Biol. Chem. 267:23216.
42. Lehrer, R. I., G. Xu, A. Abduragimov, N. N. Dinh, X. D. Qu, D. Martin, and B. J. Glasgow. 1998. Lipophilin, a novel heterodimeric protein of human tears. FEBS Lett. 432:163.
43. Lehrer, R. I., T. Nguyen, C. Zhao, C. X. Ha, and B. J. Glasgow. 2000. Secretory lipophilins: a tale of two species. Ann. N.Y. Acad. Sci. 923:59.
44. Rose, F. R., K. Bailey, J. W. Keyte, W. C. Chan, D. Greenwood, and Y. R. Mahida. 1998. Potential role of epithelial cell-derived histone H1 proteins in innate antimicrobial defense in the human gastrointestinal tract. Infect. Immun. 66:3255.
45. Steinbakk, M., C. F. Naess-Andresen, E. Lingaas, I. Dale, P. Brandtzaeg, and M. K. Fagerhol. 1990. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 336:763.
46. Cole, A. M., Y. H. Kim, S. Tahk, T. Hong, P. Weis, A. J. Waring, and T. Ganz. 2001. Calcitermin, a novel antimicrobial peptide isolated from human airway secretions. FEBS Lett. 504:5.
47. Logdberg, L., and L. Wester. 2000. Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim. Biophys. Acta 1482:284.
48. Bingle, C. D., and C. J. Craven. 2002. PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum. Mol. Genet. 11:937.